Celiac Disease Treatment Differs Between Physicians and Academics
Researchers interviewed 169 practicing gastroenterologists and 22 academic experts to determine the treatment recommended and the treatment actually given. Differences were found in the use of IgA anti-endomysial antibodies, human leukocyte antigen DQ2/8 testing, gluten challenge and oat consumption.
Academic experts more frequently recommended CD screening for patients with type 1 diabetes and Down and Turner syndromes, as well as for relatives of CD patients.
Related Articles on Celiac Disease:
Celiac Cases Rising, Cause Unknown
Mayo Clinic Gastroenterologist Details Role of Endoscopic Imaging in Small Bowel
Texas Gastroenterologist Featured for Use of Capsule Endoscopy
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- 2 legislative changes impacting ASCs — Oct. 21, 2016
- Anesthesia Business Consultants launches MACRA guidance platform: 3 notes
- IBD patients report high annual salary, educational attainment: 4 study insights
- Clinton, Trump talk Medicare plans during 3rd presidential debate — 6 highlights
- 38 ASC management & development companies to watch — 2017